Literature DB >> 1708467

Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin.

M J Besson1, A M Graybiel, B Quinn.   

Abstract

The expression of tachykinin-like and opioid-like peptides was studied in medium-sized neurons of the caudate nucleus in tissue from adult cats pretreated with colchicine. Two methods, a serial thin-section peroxidase-antiperoxidase technique and a two-fluorochrome single-section technique, were applied. Quantitative estimates were made mainly with the peroxidase-antiperoxidase method. The numbers of neurons expressing substance P-like, dynorphin B-like, and enkephalin-like immunoreactivity were recorded in regions identified, respectively, as striosomes and extrastriosomal matrix. Striosomes were defined by the presence of clustered substance P-positive and dynorphin B-positive neurons and neuropil. Tests for the co-existence of enkephalin-like peptide and glutamate decarboxylase-like immunoreactivity were also made with the peroxidase-antiperoxidase method. Co-expression of substance P-like and dynorphin B-like immunoreactivities was the rule both in striosomes and in the matrix. In striosomes, substance P-like immunoreactivity was found in 96% of dynorphin B-immunoreactive neurons, and in the matrix 89% of dynorphin B-positive cells contained substance P-like immunoreactivity. Substance P/dynorphin B-positive neurons corresponded to over half (57%) of the neurons in striosomes but only 39% of the neurons in the matrix. Both in the matrix and in striosomes, about two-thirds of all neurons (63% and 65%, respectively) were identified as enkephalin-positive. Among all substance P/dynorphin B-positive medium-sized neurons, 76% also contained enkephalin-like antigen. The enkephalin-positive neurons characterized by triple peptide co-existence (enkephalin/substance P/dynorphin B) represented a mean of 63% of striosomal enkephalin-positive neurons (41% of all striosomal neurons) and 35% of matrical enkephalin-positive neurons (26% of all matrical neurons). Finally, nearly all enkephalin-positive neurons were immunoreactive for glutamate decarboxylase, and therefore probably GABAergic, but only about half the glutamate decarboxylase-positive population was enkephalin-immunoreactive. These findings suggest that neuropeptides from three distinct precursors may be co-localized in single medium-sized neurons in the striatum, and that the differential patterns of co-expression of substance P-like, dynorphin B-like, and enkephalin-like peptides may confer functional specializations upon subpopulations of GABAergic neurons giving rise to the efferent projections of the striatum. The linked expression of substance P-like and dynorphin B-like peptides in single neurons both in striosomes and matrix suggests that some regulatory mechanisms controlling peptide expression apply regardless of compartment.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1708467     DOI: 10.1016/0306-4522(90)90220-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  22 in total

1.  Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors.

Authors:  L Tremblay; M L Kemel; M Desban; C Gauchy; J Glowinski
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 2.  Organization and physiology of the substantia nigra.

Authors:  H Condé
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

3.  The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies.

Authors:  Martin Lévesque; André Parent
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

Review 4.  A Motivational and Neuropeptidergic Hub: Anatomical and Functional Diversity within the Nucleus Accumbens Shell.

Authors:  Daniel C Castro; Michael R Bruchas
Journal:  Neuron       Date:  2019-05-08       Impact factor: 17.173

5.  Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia.

Authors:  Agnes Nadjar; Jonathan M Brotchie; Celine Guigoni; Qin Li; Shao-Bo Zhou; Gui-Jie Wang; Paula Ravenscroft; François Georges; Alan R Crossman; Erwan Bezard
Journal:  J Neurosci       Date:  2006-08-23       Impact factor: 6.167

Review 6.  Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.

Authors:  J Kulisevsky
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

7.  Coordinated expression of dopamine receptors in neostriatal medium spiny neurons.

Authors:  D J Surmeier; W J Song; Z Yan
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

8.  Genetic-Based Dissection Unveils the Inputs and Outputs of Striatal Patch and Matrix Compartments.

Authors:  Jared B Smith; Jason R Klug; Danica L Ross; Christopher D Howard; Nick G Hollon; Vivian I Ko; Hilary Hoffman; Edward M Callaway; Charles R Gerfen; Xin Jin
Journal:  Neuron       Date:  2016-08-25       Impact factor: 17.173

9.  Revised nomenclature for avian telencephalon and some related brainstem nuclei.

Authors:  Anton Reiner; David J Perkel; Laura L Bruce; Ann B Butler; András Csillag; Wayne Kuenzel; Loreta Medina; George Paxinos; Toru Shimizu; Georg Striedter; Martin Wild; Gregory F Ball; Sarah Durand; Onur Güntürkün; Diane W Lee; Claudio V Mello; Alice Powers; Stephanie A White; Gerald Hough; Lubica Kubikova; Tom V Smulders; Kazuhiro Wada; Jennifer Dugas-Ford; Scott Husband; Keiko Yamamoto; Jing Yu; Connie Siang; Erich D Jarvis; Onur Gütürkün
Journal:  J Comp Neurol       Date:  2004-05-31       Impact factor: 3.215

10.  Compartmentalization of excitatory amino acid receptors in human striatum.

Authors:  L S Dure; A B Young; J B Penney
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.